Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2A, Single-Arm Study to Evaluate the Safety and Clinical Activity of VTX2735 in Participants With Cryopyrin-Associated Periodic Syndrome (CAPS)

NCT05812781 is registered in ClinicalTrials.gov with Zomagen Biosciences Ltd. as lead sponsor.

NCT NCT05812781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05812781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2A, Single-Arm Study to Evaluate the Safety and Clinical Activity of VTX2735 in Participants With Cryopyrin-Associated Periodic Syndrome (CAPS)
Lead sponsor
Zomagen Biosciences Ltd.
Phase
Phase 2
Overall status
Completed
Start date
March 18, 2023
Completion date
March 6, 2024
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cryopyrin associated periodic syndrome